Wed. 13 Mar 2024, 4:07pm ET
Benzinga
Earnings, Earnings Beats, News
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.42) by 16.67 percent. This is a 16.67 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $6.096 million which beat the analyst consensus estimate of $5.525 million by 10.33 percent.